Rewind Therapeutics

Rewind Therapeutics

Latest funding
€15,200,000
Venture capital (Series A) - 2018
Boehringer Ingelheim Venture Fund ParticipatieMaatschappij Vlaanderen Merck Ventures BV +2
Team Size
1–10
Employees
Location
Headquarters
€15,200,000 Venture capital (Series A)
PE Hub

| Belgian biotech company Rewind Therapeutics picks up Series A funding